Delivery Order SPE2DB22D2006-SPE2DB25FW4CC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets in quantities of 100 units. This is a competitively awarded, firm fixed price contract with no set-aside designation, valued at $1,474.20 and scheduled for completion by August 29, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,258.58 delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) on July 31, 2025, with completion expected by August 1, 2025. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.87 firm-fixed-price delivery order, awarded on February 11, 2025, is for BUTALBITAL-ASPIRIN-CAFFEINE CP 100S, a pharmaceutical product, with a completion date of February 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,797.80 firm fixed-price contract is for the delivery of butalbital-aspirin-caffeine medication. The contract has an ultimate completion date of January 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.65, covers the delivery of 4567009809 ! BUTALB-ACETAMIN-CAFF 50-325-40 100S medication. The award has an ultimate completion date of January 23, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty thousand six dollars to Amerisourcebergen Drug Corporation for the supply of 4561823734 BUTALB-ACETAMIN-CAFF 50-325-40 100S. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for a one day period beginning on August 15th and concluding on August 16th of 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will serve...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,354.22, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
- This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corp $712 to supply BUTALBITAL-ASPIRIN-CAFFEINE CP 90S. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products from its place of performance in Conshohocken, Pennsylvania by October 12, 2023. The parent company, Amerisourcebergen Corporation, will support delivery under this firm fixed price, non-set aside contract. No major subcontractors were identified. This...
- The Defense Logistics Agency awarded a $1,028.73 firm fixed price delivery order to Amerisourcebergen Drug Corporation for BUTALBITAL-ASPIRIN-CAFFEINE combination pills. Under this contract, Amerisourcebergen will deliver 100 units of the medication to a location in Conshohocken, Pennsylvania by September 18, 2023 to support DLA requirements. No additional details were provided regarding the original solicitation or use of the products. Amerisourcebergen will perform as the prime contractor...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-one thousand two hundred fifty dollars to Amerisourcebergen Drug Corporation for the product "4561491721 ! BUTALB-ACETAMIN-CAFF 50-325-40 500S." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 13, 2023 through July 14, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4CCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,997.78 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg tablets (100 count). This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider serving federal medical procurement needs. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs globally. The company's demonstrated capacity to fulfill federal medical supply requirements through open competition, combined with its extensive portfolio of pharmaceutical deliveries to military and veteran healthcare systems, positions it as a critical vendor within DLA's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/9/25 |